| INTRODUC TI ON

Summary
Autophagy is an essential cellular process concern with cellular homeostasis downregulated by mTOR, whose activity can be modulated by rapamycin, a kind of lipophilic macrolide antibiotic, through forming a complex with immunophilin FKBP12
essential for mTOR regulation to induce autophagy. Therefore, rapamycin is normally used as a neuron protective agent. The immunophilin FKBP12 binding ligand FK506
is well known as an immunosuppressive agent by inhibiting the calcineurin expression. In this study, we synthesized a series of modified compounds based on the FKBP12 binding moiety to as same as the binding structure of rapamycin and FK506
particularly. We removed the other binding regions of the complex that has the property of immunosuppression. We found that a novel small molecule named TH2849 from these derivative compounds has a significant binding connection with mTOR by comparing to calcineurin. The effects of TH2849 on calcineurin/NFAT were not as significant as FK506, and weak effects on IL2/p34 cdc2 /cyclin signaling pathway were also found. Moreover, TH2849 also shows mitochondrial protective effect through stabilizing the mitochondrial structure and transmembrane potential (ΔΨm) and could rescue dopaminergic neurons in MPTP-treated zebrafishes as well as mice models with less immunosuppressive effect. Our present study shows that TH2849
works as a neuroprotective agent possibly by inducing autophagy and low immunosuppressive effect.
K E Y W O R D S
autophagy, FK506, low immunosuppression, mitochondria protection, neurodegenerative diseases, rapamycin disease (PD) is characterized by loss of pigmental neurons and the presence of Lewy bodies due to mutants of α-synuclein, such as A53T and A30P. 4 The aggregation of proteins is positively correlated with toxicity, which could lead to neuron necrosis. Moreover, the accumulation of aggregated and toxic protein complex leads to central neurodegeneration.
It has been reported that the autophagy is a cellular process of self-digesting 5 initiating from an isolation membrane, which can engulf the cytosolic components including long-lived or aggregateprone proteins, superfluous or damaged organelles, and invading pathogens, and then deliver these to lysosomes for degradation. 6 Therefore, a suitable way to protect neuron from impairment is to regulate the aberrant aggregation of the protein in CNS or brain by induction of autophagy.
The target of rapamycin (mTOR) is the major inhibitory signal that can shut off autophagy in the presence of abundant nutrients, growth factors, and a major representative component of autophagy cell cycle process. Rapamycin is a ligand to immunophilin FKBP12, which has been documented for binding an immunosuppressive agent FK506 with high affinity. 7 The rapamycin-FKBP12 form a complex that directly interacts with mTOR, 8 blocking its activity, which leads to autophagy induction. Previous studies have reported that rapamycin could modulate the levels of both soluble mutant huntingtin proteins and the aggregated forms in the HD model of Drosophila and mouse. 9 Also, the animal studies with rapamycin treatment have been
shown that the mutant form of α-synuclein is associated with PD. 10 However, though rapamycin has the potential to cure neurodegenerative diseases, its role as an immunosuppressive agent largely constrained its application of an effective neuron protective drug.
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In this study, not only we introduced a series of novel rapamycin and FK506 derivative compounds based on the FKBP12 binding moiety by imitating the binding structure of rapamycin and FK506 particularly, but also we screened a compound, TH2849, from these derivatives that can work as a neuroprotective agent probably by inducing autophagy with low immunosuppressive effect. were from Beyotime Biotechnology (Shanghai, China).
| MATERIAL S AND ME THODS
| Reagents
| Plasmids, siRNA, and transfection
The EGFP-LC3 plasmid was kindly provided by Professor Marja Jäättelä.
EGFP-HDQ23, EGFP-HDQ74, and EGFP-A53T α-synuclein plasmids were kindly provided by Professor David C. Rubinsztein. The NFATc1 cDNA was amplified using PCR primers and cloned into the pEGFP-C1 vectors.
All plasmid constructs were confirmed by automated DNA sequencing.
Cells were transiently transfected with expression plasmids and reporter vectors using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Chemically synthesized siRNAs specifically targeting FKBP12, as previously reported 12 , were purchased from GenePharma (GenePharma Co., Ltd., Shanghai, China).
| Cell culture
U251 and PC12 cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco, Carlsbad, CA, USA) with 10% heat-inactivated fetal bovine serum (FBS, Gibco) at 37°C in 5% CO 2 . CTLL-2 cells were maintained in RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (FBS, Gibco) at 37°C in 5% CO 2 .
| Autophagy assays
The cells were transfected with EGFP-LC3 with Lipofectamine 2000 with different treatments for 24 hours, and then, the cells were fixed in 4% paraformaldehyde. The cells with fluorescent dots representing EGFP-LC3 translocation were counted by confocal microscopy as described previously. 13 Confocal microscopy was performed on an FLUO-VIEW laser scanning confocal microscope (Olympus, FV1000, Olympus Optical, Tokyo, Japan) in sequential scanning mode using a 60× objective. LC3II levels were detected using the antibody against LC3.
| Mutant huntingtin protein aggregation assay
After 48 hours posttransfection with EGFP-HDQ74, the cells were left untreated or subjected to different treatments as indicated and then fixed in 4% paraformaldehyde. Cells with EGFP-HDQ74 aggregation were counted by confocal microscopy as described previously. 
| Clearance of mutant A53T α-synuclein assay
The assay to measure the clearance of mutant A53Tα-synuclein was performed as described previously. 14 Briefly, cells were transfected with A53T α-synuclein for 24 hours and then left untreated or subjected to different treatments as indicated. Clearance of soluble A53T α-synuclein was detected using the anti-EGFP antibody.
| Immunoblotting
Immunoblotting analysis was performed as previously described.
For abbreviation, cell lysates were resolved on 8%-12% SDS-PAGE and analyzed by immunoblotting using primary antibodies, followed by enhanced chemiluminescence (ECL) detection (Thermo Fisher Scientific, Waltham, MA, USA).
| Computer modeling
The AutoDock Vina 1.1.2 was used for all dockings in this study. 
| Zebrafish PD model and whole-mount in situ hybridization
Zebrafish were maintained as previously described. 17 Embryos were collected and dechorionated at 3-5 hours postfertilization.
Dechorionated embryos were transferred to 6-well plates. After antisense RNA probes were generated in vitro using the zebrafish dat cDNAs as templates with RNA polymerase (Promega, Madison, WI, USA). RNA whole-mount in situ hybridizations were performed as described by Westfield. 17 After in situ hybridization, embryos were transferred into glycerol, equilibrated for 10 minutes, and then placed on a slide and flattened softly using a coverslip to disperse the neurons. The number of dat-positive neurons in the diencephalon region was counted.
| MPTP treatments in mice
The over an 8-hours period in 1 day as described previously. 18, 19 The mice received two intraperitoneal injection of rapamycin (10 mg/ kg), FK506 (12 mg/kg), TH2849 (10 mg/kg), and TH2451 (10 mg/ kg) in vehicle (4% ethanol, 5% Tween 80%, and 5% PEG400) every 12 hours for 2 days before the first MPTP/saline injection and continued for 4 days after the last MPTP/saline injection as described previously. 18, 19 The mice were killed, and their brains were used for biochemical analysis.
| Immunohistochemistry and Immunofluorescence
Immunohistochemically analysis was performed as previously described. For abbreviation, the brain frozen sections were incubated with primary antibody against tyrosine hydroxylase (TH). The biotinylated secondary antibody and avidin-conjugated peroxidase and 3, 3 diaminobenzidine tetrachloride (DAB) substrate were used to detect the primary antibody, and hematoxylin was used as counterstain. For Immunofluorescence, the TRITC secondary antibody was used to detect the primary antibody. The total number of TH-positive SNPC neuron on each section was counted in various groups.
| Statistics analysis
Differences between groups were compared by Student's t test (*P < 0.05; **P < 0.01; ***P < 0.001). The data were presented as means ± SE.
| RE SULTS
| Screening Rapamycin and FK506 derivatives potentially to regulate autophagy induction
Rapamycin and FK506 both have similarity in the ring structure with a high binding affinity to the immunophilin FKBP12. This moiety composed of a C1 ester, pipecolinyl ring, and C8 and C9 carbonyls (FKBP12 binding moiety). 20 After successful synthesis of this moiety structure, we renamed it as TH2451 as shown in Figure 1A . We modified TH2451 based on their rudimentary structure by a series of ramification. Autophagy is an essential cellular process concern to maintain the cellular fluid balance and eliminate the aggregate-prone and toxic within the cell to play a key role in the various stages of tumorigenesis. 21 Therefore, to examine whether these derivatives have the ability to induce autophagy, we investigated the autophagosome (LC3-positive vesicle) formation after treatment with the rapamycin, FK506, and TH compounds for 24 hours. We found that the substantial autophagosomes were induced with the treatment of rapamycin, TH2451, TH2849, TH2287, and TH3263 in the U251
and PC12 cells ( Figure 1B ,C). Furthermore, we examined the protein levels of p62, a substrate of autophagy, and LC3II, which is produced by the cleavage of the C-terminal LC3 proteins when autophagy initiates. 22 Our result suggests that treating U251 cells with rapamycin, TH2849, and TH2287 could dramatically decrease the level of p62 protein but increase the level of LC3-II protein ( Figure 1D -F).
Altogether, our results implied that TH2849 and TH2287 derivatives may have a strong effect in the regulation of autophagy as same as rapamycin.
| TH derivative compounds modulate the protein aggregate-prone and toxic effects in vitro
Next, we examined to assess the elimination efficacy of abnormal protein aggregation by TH compounds. The huntingtin exon 1 with the 74Q mutation (HDQ74) and A53T α-synuclein (a mutant of α-synuclein) were used to simulate HD and PD. 
| Computer model simulates different TH compounds binding with FKBP12, mTOR, and calcineurin
Immunophilin FKBP12 is a receptor that can be bound by rapamycin and FK506 with significantly triggering a downstream reaction.
However, TH compounds binding to moiety structure to form a complex with FKBP12 still need confirmation. Therefore, computer modeling of the binding of the TH compounds with FKBP12 was then carried out. As shown in Figure 3 , all TH compounds, rapamycin, and FK506 shared the same binding site with FKBP12.
Rapamycin-FKBP12 and FK506-FKBP12 complexes have been reported to bind to mTOR to trigger autophagy, and calcineurin to cause immunosuppression, respectively. These data suggested that the TH2849-FKBP12 complex rather than TH2287-FKBP12 or TH3263-FKBP12 complex has the best structure to effectively bind mTOR, but the most inappropriate steric configuration to interact with calcineurin.
| TH2849 may induce autophagy through inhibition of mTOR activation and activation of ULK1
The target of rapamycin (mTOR)regulation is essential for autophagy induction through suppressing the ULK1 complex. 27 During starvation or growth factor withdrawal, mTOR is inactivated, and autophagy initiates. The previous studies have been reported that the rapamycin can modulate the activation of mTOR and induce autophagy. 28 Previous studies 27 have shown that ULK1 enhances the mTOR activity. When under nutrient condition, ULK1 is phosphorylated by mTOR, which leads the dissociation of ULK1 with Atg13. 27 However, during starvation or stimulation with mTOR inhibitor, ULK1 is dephosphorylated and forms a complex with Atg13, FIP200, and ATG101, which initiates the autophagy. 29 Therefore, we observed 
| TH2849 induces autophagy by forming a complex with FKBP12 without interfering to the calcineurin/NFAT and IL2/p34 cdc2 /cyclin A signal pathway
According to the prediction of computer modeling, TH2849 has a binding ability to FKBP12. Therefore, we conducted biological experiment to confirm it. By knocking down FKBP12 with siRNA, we found that the autophagy failed to be activated though with treatment of rapamycin, TH2451, and TH2849 in PC12 cells ( Figure 5A -C). These data demonstrated that TH2849 and TH2451 may induce autophagy through binding FKBP12.
Meanwhile, due to the nonspecific interaction between TH2849
and calcineurin calculated by the bioinformatics model, we next investigated the role of TH2849 on calcineurin/NFAT signal pathway which is essential for immune system activation. Calcineurin is a calcium/calmodulin-dependent serine-threonine protein phosphatase. 30 Previous studies have been reported that the calcineurin activation cause by the high level of cytoplasmic calcium which leads to the transcription factor of activated T cell (NFATc) dephosphorylated and translocation into the nucleus. This will up-regulate the transcription of interleukin genes such as IL-2, IL-4, and IL-6, which play vital role in the stimulation of T-helper lymphocytes and other cytokines. 31 The FK506-FKBP12 complex inhibits the calcineurin; therefore, FK506 has been broadly applied as an immunosuppressive drug. 32 We managed to detect the nuclear translocation of NFATc1 to value the contribution of TH2849 in suppressing calcineurin/ NFAT signal pathway. After incubation with different compounds and stimulation with ionomycin in the EGFP-NFATc1 transfected CTLL-2 cells, the confocal images showed that the nucleus translocation of NFATc1 was not significantly blocked by rapamycin and TH2849 comparing with FK506, TH2451, TH3263, and TH2287
( Figure 5D ,E).
It has been reported that rapamycin works as a immunosuppressive mainly counting on this IL2/p34 cdc2 /cyclin A signal pathway drives stimulated T cells through a late G1-phase into Sphase. [33] [34] [35] During late G1-phase, two cyclin-dependent kinases, p34 cdc2 and p33 cdk2 , participate in the sequence of events contributing to S-phase commitment and then help to activate different cyclins such as cyclin A, cyclin D, and cyclin E. 
| TH2849 shows protective mechanism in MPTP-induced PD model
To investigate the TH2849 neuron protective effect in vivo, we developed the acute injury PD models in zebrafishes and mice by MPTP.
When the zebrafishes or mice were treated with MPTP, the significantly dopaminergic neurons loss was found ( Figure 7A,B) . Meanwhile, we also found that TH2849 could rescue dopaminergic neurons in 
| D ISCUSS I ON
Previous studies have shown that the clearance of mutant huntingtin proteins (HDQ74) and mutant α-synuclein (A53T α-synuclein)
is largely mediated by autophagy. 14 Up-regulation of autophagy is a capable way to cure neurodegenerative diseases by inhibiting the mTOR; especially, rapamycin could efficiently up-regulate autophagy and eliminate both of the levels of soluble and the aggregated mutant huntingtin protein in Drosophila and mouse models of HD. 9 The treatment of mice expressing the mutant form of α-synuclein associated with PD with rapamycin also could regulate the neuronal toxicity. 10 Although, up-regulation of autophagy through mTOR-dependent pathway is a promising strategy for the treatment of neurodegenerative diseases; however, rapamycin might not be suitable for a long-term use in human body 11 because mTOR is the most important signal pathway in controlling the cell growth, which regulates the ribosome biogenesis, protein translation. Moreover, rapamycin is widely used as a immunosuppressive agent, which significantly down-regulates IL2/p34 cdc2 /cyclin A signal pathway, impairs wound healing, and displays immunosuppressive effects . 8, 11, 39 It has been reported that the rapamycin inhibits mTOR through binding FKBP12. FK506 also can bind FKBP12 but has very different downstream mechanism, which is the inhibitor of calcineurin/NFAT , and TH2451 (10 mg/kg) every 12 h for 6 d, and then, the blood serum was collected and used to detect the IL-2 (C) and IL-6 (D). All the substances were dissolved in DMSO. Scale bars: 10 μm. Data are shown as the mean ± SEM *P < 0.05, **P < 0.01, ***P < 0.001 compared to DMSO control, n = 5 [Colour figure can be viewed at wileyonlinelibrary.com] protect from degradation. We also found that FK506 works as an immunosuppressive agent due to suppressing the calcineurin/NFAT signal pathway, which supports the published data. 39 Our results showed that the rapamycin and FK506 all have high affinity to bind FKBP12 on account of sharing a similar large ring structure, which consists of the C1 ester, the pipecolinyl ring, and the C8 and C9 carbonyls. We synthesized a rapamycin and FK506 renamed as TH compounds, and then, we screened out four TH compounds (TH2451, TH2849, TH2287, and TH3263) from these derivatives. Next, we examined and found that the derivative po- In terms ofthe immunosuppression effect of these TH compounds, as predicted by the computer modeling, the immunofluorescence result showed that TH2849 did not have any inhibition function on nuclear translocation of NFATc1, which means it would not impact calcineurin/NFAT signal pathway compared with FK506.
Meanwhile, we continued to investigate the effect of TH2849 on IL2/p34 cdc2 /cyclin A signal pathway, which is the key mechanism why rapamycin can be applied as an immunosuppressive agent. [33] [34] [35] Normally, the stimulation of interleukin-2 (IL-2) results in T cells through a late G1-phase into S-phase. 43 Two cyclin-dependent kinases, p34 cdc2 and p33 cdk2 , help to activate different cyclins such as cyclin A, cyclin D, and cyclin E. 36, 37 However, unlike rapamycin, we did not found a significant effect of TH2849 on the IL2/p34 cdc2 / cyclin A signal pathway. But the reason accounting for this remains elusive.
Mitochondrial is a critical organelle for regulation of cell death and damaging of mitochondrial caused by mutations of mitochondrial DNA and oxidative stress leading to disease pathogenesis. 3 The genes leading to PD pathogenesis also implicate associated with mitochondria mutated gene include α-synuclein, parkin, DJ-1, PINK1, But we also notice that the interaction between TH2849 and mTOR is not as specific as that between rapamycin and mTOR. After all, rapamycin has the strongest effect on eliciting autophagy and neuroprotection in our experiments. Some researchers argue that neuroprotection is associated with immunophilins other than FKBP12, notably FKBP52 and FKBP38, 44 ,45 which we guess may be the potential reason why our TH compounds cannot reach the perfect neuroprotection performance. Furthermore, from the literature we found other structure-based rapamycin derivative design approach, such as ILS-920 and WYE-592, two semi-synthetic analogs of rapamycin that were also nonimmunosuppressive. 46 These two analogs showed unanticipated selectivity for FKBP52 (over 200-fold selectivity for FKBP52 versus FKBP12); thus, they owned better neuron protection effect compared with rapamycin. But it should also be noticed that these two compounds were only reported to be effective on ischemic stroke and that little is known about its therapeutic effect on several typical neurodegenerative diseases, such as PD, AD, and HD.
| CON CLUS IONS
In this study, we screened out a compound TH2849 which could retain the neuron protective effect of rapamycin but without 
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